100 results
DEFA14A
SAGE
Sage Therapeutics Inc
24 Apr 24
Additional proxy soliciting materials
4:10pm
the compensation paid to our named executive officers. For 4. To approve the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. For NOTE: To transact
SC TO-I/A
SAGE
Sage Therapeutics Inc
27 Mar 24
Issuer tender offer statement (amended)
4:09pm
of the Company’s common stock, pursuant to the terms of the Offer to Exchange and the 2014 Stock Option and Incentive Plan. The exercise price per share
SC TO-I/A
SAGE
Sage Therapeutics Inc
21 Feb 24
Issuer tender offer statement (amended)
4:35pm
shares of the Company’s common stock, pursuant to the terms of the Offer to Exchange and the 2014 Stock Option and Incentive Plan. The exercise price
S-8
pukqxd0q4gdxo0oxw9nb
14 Feb 24
Registration of securities for employees
7:49am
S-8
EX-5.1
u1xlq5cl0wwv
14 Feb 24
Registration of securities for employees
7:49am
SC TO-I/A
w4hzw8mv22n7e6ggsar8
31 Jan 24
Issuer tender offer statement (amended)
5:25pm
SC TO-I
EX-99
butkp9na
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
EX-99
ao9r89
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
u3qml
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
EX-99
0g6 89gyicui860
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
EX-99
cx9vunqhfoh 8xsu5tju
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
EX-99
3vnhb
23 Jan 24
Issuer tender offer statement
8:13am
SC TO-I
EX-99
2y1l62 jtpg
23 Jan 24
Issuer tender offer statement
8:13am
PRE 14A
luh5d
8 Dec 23
Preliminary proxy
8:30am
8-K
EX-1.1
vo5b1nynp8tf
7 Nov 23
Entry into a Material Definitive Agreement
7:39am